Revvity | PKI - Cash And Equivalent


Revvity reported $1.02B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Align Technology USD 1.1B 42.76M Jun/2026
Bio Techne USD 209.82M 36.94M Mar/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Danaher USD 4.35B 1.35B Jun/2026
Dentsply International USD 239M 49M Jun/2026
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Illumina USD 1.09B 329M Mar/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 141.8M 839.3M Jun/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pacific Biosciences Of California USD 61M 4.73M Jun/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
Qiagen NV USD 646.29M 192.72M Mar/2026
Quest Diagnostics USD 626M 233M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Repligen USD 606.78M 24.13M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
Waters USD 539M 77M Jun/2026
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026